185 related articles for article (PubMed ID: 31460783)
1. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Zhao J; Wang L; Kong D; Hu G; Wei B
J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783
[TBL] [Abstract][Full Text] [Related]
2. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
3. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
6. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
7. A thirteen‑gene set efficiently predicts the prognosis of glioblastoma.
Yang H; Jin L; Sun X
Mol Med Rep; 2019 Mar; 19(3):1613-1621. PubMed ID: 30628650
[TBL] [Abstract][Full Text] [Related]
8. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
11. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Wang H; Liu D; Yang J
Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
[TBL] [Abstract][Full Text] [Related]
12. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
13. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Ke H; Wu Y; Wang R; Wu X
Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
[TBL] [Abstract][Full Text] [Related]
14. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
15. lncRNA and mRNA signature for prognosis prediction of glioblastoma.
Liu G; Pan Y; Li Y; Xu H
Future Oncol; 2020 May; 16(13):837-848. PubMed ID: 32250161
[No Abstract] [Full Text] [Related]
16. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
[TBL] [Abstract][Full Text] [Related]
17. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling identifies potentially significant epigenetically-regulated genes in glioblastoma multiforme.
Kan S; Chai S; Chen W; Yu B
Oncol Lett; 2019 Aug; 18(2):1679-1688. PubMed ID: 31423235
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon Cancer.
Wu Y; Wan X; Jia G; Xu Z; Tao Y; Song Z; Du T
DNA Cell Biol; 2020 Nov; 39(11):1961-1969. PubMed ID: 33085517
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
[Next] [New Search]